
“In April, an expert advisory panel for the FDA voted unanimously to recommend Epidiolex’s approval and determined that ‘CBD has a negligible abuse potential.’ The DEA did not immediately respond to Ars’ request for comment. But GW said it expects that the DEA will reschedule CBD within 90 days.”
Related posts:
Last Week’s Mortgage Applications Were at a 13-Year Low
Illinois governor Pat Quinn signs new ‘background checks’ law
3 Acts of American Education System Insanity
Red Tape Strangulation: 3,600 New Federal Rules in 2013
Yes, You Are A Criminal... You Just Don't Know It Yet
The ACLU Has Basically Quit Defending The Constitution
Bitcoin and the New Fourth Estate: An Interview with Cop Block
Syria’s Game of Thrones: Obama backs Al Qaida and the Chechen terrorists
Review: Ploom Model Two
Flooded By Gold Smuggling, India's New Cabinet To Lift Gold Controls
Why doctors are more dangerous than guns
The Ten Most Disturbing Things You Should Know About the FBI Since 9/11
Globalist Euro Disaster: Euro Founder Endorses Bust-Up
Watch Iran's $40-Million Oil Rig Collapse Into The Sea
Mastercoin, Bitshares, ColoredCoins Form Self-Regulatory Organization